skip to content
https://research-5iresearch.lpages.co/free-trial-5i-research-5i-blog/
Detailed Quote
5i Report
Rating
B

Review of Covalon Technologies

JUL 17, 2018 - Healthcare company that sells products related to wound care and infection control. Recent contracts make it particularly interesting. Initiating coverage at a 'B' rating.

Download Report
Company Profile
Interactive Chart
Key Ratios
Top Banner 5i Free Trial
Earnings
Analyst Recommendations
5i Recent Questions

Q: I held CXR when it was over $100.00 and added to it on the way down. Eventually at $25.00, myself and 5i members were waiting for the quarter and after the report, it dropped to $12.00 and 5i said they were getting out of it. So did I. The same thing happened with RHT. I am concerned that COV a $9.00 plus stock now in the $6 plus range, seems to be repeating the pattern of the two above-mentioned stocks. My question is do you see the same thing happening again with this stock? Thanks Dennis

Read Answer Asked by Dennis on October 17, 2018

Q: As a member of 5i since 2013 I have used your wise logic as one of the tools to help me position my portfolio. I have had some Major wins with your help, but this has been a gut wrenching experience and I have learned the hard way that keeping a reasonable weighting of any one stock is of paramount importance. I let RHT get too large a weighting and believed in their product as a way to help people. It concerns me that you used the word 'fraud' in one of your previous replies.
I have now reduced most of my position to a very small weighting and am reviewing selling it all.
I have a position in COV that is a full position. It is a bit weak of late but I think that is due to the Saudi Arabian rhetoric and is a temporary blip.
Would you consider VMD to be a good replacement for RHT.

Thanks for all your solid advise in these turbulent times.

Peter

Read Answer Asked by Peter on October 16, 2018
Insiders
5i Free Trial 300x250
Share Information
News and Media